The Kellys, who lives in Seattle, consented to participate in a clinical trial at the neighboring FHCRC (Fred Hutchinson Cancer Research Center) as part of a global effort to test an antiviral drug that could stop Covid early, immediately after their diagnosis. At least three good antivirals for Covid are being tested in clinical trials, according to Carl Dieffenbach, director of AIDS division at the NIAID (National Institute of Allergy and Infectious Diseases), who is overseeing antiviral development. In the same month, the administration announced a $3.2 billion investment in the Antiviral Program for Pandemics, which intends to develop antivirals for the Covid issue and beyond, according to Dieffenbach.